Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)
Clinical trial NCT02014636 · COMPLETED
Trial details
- NCT number
- NCT02014636
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-27
- Primary completion
- 2019-02-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.